Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruin Moaddel

Showing results (101-110 of 217) with videos related to

Pageof 22
Sort By:
Molecular Psychiatry|March 1, 2018
Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjectsAllison C Nugent, Elizabeth D Ballard, Todd D Gould, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 23, 2023
Identification of glycolytic proteins as binding partners of Bri2 BRICHOS domainHelene Tigro, Makoto Shimozawa, Per Nilsson, et al.
Journal of Chromatography. A|November 22, 2005
Development and characterization of an immobilized enzyme reactor (IMER) based on human glyceraldehyde-3-phosphate dehydrogenase for on-line enzymatic studiesCarmem L Cardoso, Virginia V Lima, Aderson Zottis, et al.
The International Journal of Biochemistry & Cell Biology|August 5, 2010
Interaction of ibogaine with human alpha3beta4-nicotinic acetylcholine receptors in different conformational statesHugo R Arias, Avraham Rosenberg, Katarzyna M Targowska-Duda, et al.
Analytical Chemistry|December 8, 2007
Initial synthesis and characterization of an alpha7 nicotinic receptor cellular membrane affinity chromatography column: effect of receptor subtype and cell typeRuin Moaddel, Regina V Oliveira, Tomoko Kimura, et al.
Pharmacology Research & Perspectives|July 15, 2015
The distribution and clearance of (2S,6S)-hydroxynorketamine, an active ketamine metabolite, in Wistar ratsRuin Moaddel, Mitesh Sanghvi, Katina Sourou Sylvestre Dossou, et al.
Biological Psychiatry|April 21, 2012
Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depressionCarlos A Zarate, Nancy Brutsche, Gonzalo Laje, et al.
Aging Cell|March 21, 2020
Proteomic signatures of in vivo muscle oxidative capacity in healthy adultsFatemeh Adelnia, Ceereena Ubaida-Mohien, Ruin Moaddel, et al.
Talanta|October 24, 2013
Acetylcholinesterase immobilized capillary reactors coupled to protein coated magnetic beads: a new tool for plant extract ligand screeningKenia Lourenço Vanzolini, Zhengjin Jiang, Xiaoqi Zhang, et al.
Scientific Reports|November 25, 2020
Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington's disease for participants of varying functional disability: a pilot studyAndrew McGarry, John Gaughan, Cory Hackmyer, et al.
Pageof 22

Showing results (101-110 of 217) with videos related to

Sort By:
Pageof 22
Molecular Psychiatry|March 1, 2018
Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjectsAllison C Nugent, Elizabeth D Ballard, Todd D Gould, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 23, 2023
Identification of glycolytic proteins as binding partners of Bri2 BRICHOS domainHelene Tigro, Makoto Shimozawa, Per Nilsson, et al.
Journal of Chromatography. A|November 22, 2005
Development and characterization of an immobilized enzyme reactor (IMER) based on human glyceraldehyde-3-phosphate dehydrogenase for on-line enzymatic studiesCarmem L Cardoso, Virginia V Lima, Aderson Zottis, et al.
The International Journal of Biochemistry & Cell Biology|August 5, 2010
Interaction of ibogaine with human alpha3beta4-nicotinic acetylcholine receptors in different conformational statesHugo R Arias, Avraham Rosenberg, Katarzyna M Targowska-Duda, et al.
Analytical Chemistry|December 8, 2007
Initial synthesis and characterization of an alpha7 nicotinic receptor cellular membrane affinity chromatography column: effect of receptor subtype and cell typeRuin Moaddel, Regina V Oliveira, Tomoko Kimura, et al.
Pharmacology Research & Perspectives|July 15, 2015
The distribution and clearance of (2S,6S)-hydroxynorketamine, an active ketamine metabolite, in Wistar ratsRuin Moaddel, Mitesh Sanghvi, Katina Sourou Sylvestre Dossou, et al.
Biological Psychiatry|April 21, 2012
Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depressionCarlos A Zarate, Nancy Brutsche, Gonzalo Laje, et al.
Aging Cell|March 21, 2020
Proteomic signatures of in vivo muscle oxidative capacity in healthy adultsFatemeh Adelnia, Ceereena Ubaida-Mohien, Ruin Moaddel, et al.
Talanta|October 24, 2013
Acetylcholinesterase immobilized capillary reactors coupled to protein coated magnetic beads: a new tool for plant extract ligand screeningKenia Lourenço Vanzolini, Zhengjin Jiang, Xiaoqi Zhang, et al.
Scientific Reports|November 25, 2020
Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington's disease for participants of varying functional disability: a pilot studyAndrew McGarry, John Gaughan, Cory Hackmyer, et al.
Pageof 22